[On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].
D000319:Adrenergic beta-Antagonists; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D011412:Propanolamines / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*; D011773:Pyruvates / Q000097:blood; D013318:Stroke Volume / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D011412:Propanolamines; D011773:Pyruvates; C011550:talinolol; D011433:Propranolol
Zur Kreislaufwirkung und beta-adrenergen Blockade von Talinolol (Cordanum) und Propranolol bei wiederholter oraler Applikation am Beagle-Hund.